Metabolix Announces Termination of Telles Joint Venture
Metabolix, Inc. (NASDAQ: MBLX), today announced that the Archer Daniels Midland Company has given notice of termination of the Telles, LLC joint venture for PHA bioplastics. The effective date of the termination will be February 8, 2012. Metabolix will hold a webcast conference call for investors today at 5:00 pm EST.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.